NCT07418775 Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
| NCT ID | NCT07418775 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Meningioma of Brain |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2026-01-16 |
| Primary Completion | 2031-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2026-01-16 with a primary completion date of 2031-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.
Eligibility Criteria
Inclusion Criteria: * Adults ≥18 years of age * Able to speak and read English * Diagnosed with a meningioma Exclusion Criteria: * Active psychiatric issues (suicidality, active psychosis, grave disability, etc.) * Inability to consent secondary to severe neurologic deficit or psychiatric distress * Inability to complete survey secondary to severe neurologic deficit or psychiatric distress
Contact & Investigator
David Raleigh, MD, PhD
PRINCIPAL INVESTIGATOR
University of California, San Francisco, San Francisco, California 94143
Frequently Asked Questions
Who can join the NCT07418775 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Meningioma of Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07418775 currently recruiting?
Yes, NCT07418775 is actively recruiting participants. Contact the research team at zora.arum2@ucsf.edu for enrollment information.
Where is the NCT07418775 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07418775 clinical trial?
NCT07418775 is sponsored by University of California, San Francisco. The principal investigator is David Raleigh, MD, PhD at University of California, San Francisco, San Francisco, California 94143. The trial plans to enroll 3,000 participants.